Symbols / AIDX Stock $1.55 +0.64% 20/20 Biolabs, Inc.
AIDX (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Ratings
- AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart - MEXC Mon, 27 Apr 2026 11
- Warrant strike cut to $2.25 as 20/20 Biolabs (NASDAQ: AIDX) registers 10.1M shares - Stock Titan ue, 28 Apr 2026 11
- symbol__ Stock Quote Price and Forecast - CNN Fri, 20 Feb 2026 20
- AIDX.CA Ownership | HEALWELL AI INC (TSX:AIDX) - ChartMill Fri, 24 Apr 2026 07
- AIDX | 20/20 Biolabs, Inc. Common Insider Trading - Quiver Quantitative hu, 16 Apr 2026 04
- The past five years for Healwell AI (TSE:AIDX) investors has not been profitable - Yahoo Finance Wed, 31 Dec 2025 08
- HEALWELL AI (TSX: AIDX) Makes TSX Top Gainer List on Multi-Million Dollar U.S. HIE Contract - Investorideas.com hu, 05 Mar 2026 08
- AIDX Stock Price and Chart — NASDAQ:AIDX - TradingView Wed, 18 Feb 2026 08
- Streeterville warrant repricing at 20/20 Biolabs (NASDAQ: AIDX) drops strike - Stock Titan ue, 28 Apr 2026 11
- An Intrinsic Calculation For Healwell AI Inc. (TSE:AIDX) Suggests It's 30% Undervalued - Yahoo Finance Fri, 06 Feb 2026 08
- How The Healwell AI (TSX:AIDX) Investment Story Is Shifting With Recut Targets And Growth Assumptions - Yahoo Finance Sun, 22 Mar 2026 07
- Cancer test reaches 40,000 practitioners through Evexia platform - Stock Titan ue, 07 Apr 2026 07
- Individual investors among Healwell AI Inc.'s (TSE:AIDX) largest stockholders and were hit after last week's 14% price drop - Yahoo Finance Wed, 12 Nov 2025 08
- [EFFECT] 20/20 Biolabs, Inc. SEC Filing - Stock Titan hu, 09 Apr 2026 07
- COO of 20/20 Biolabs (AIDX) granted 150,000 options at $1.88 - Stock Titan Mon, 06 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
2.05
+16.71%
|
1.75
+23.03%
|
1.42
|
| Operating Revenue |
|
2.05
+16.71%
|
1.75
+23.03%
|
1.42
|
| Cost Of Revenue |
|
1.44
+3.49%
|
1.39
+5.84%
|
1.32
|
| Reconciled Cost Of Revenue |
|
1.44
+3.49%
|
1.39
+5.84%
|
1.32
|
| Gross Profit |
|
0.60
+67.78%
|
0.36
+230.14%
|
0.11
|
| Operating Expense |
|
3.94
-34.64%
|
6.02
-6.94%
|
6.47
|
| Research And Development |
|
0.59
-53.04%
|
1.26
-10.46%
|
1.41
|
| Selling General And Administration |
|
3.34
-29.77%
|
4.76
-5.96%
|
5.06
|
| General And Administrative Expense |
|
—
|
4.76
-5.96%
|
5.06
|
| Salaries And Wages |
|
—
|
1.55
+73.79%
|
0.89
|
| Other Gand A |
|
—
|
3.21
-23.03%
|
4.17
|
| Total Expenses |
|
5.38
-27.48%
|
7.41
-4.78%
|
7.79
|
| Operating Income |
|
-3.33
+41.16%
|
-5.66
+11.01%
|
-6.36
|
| Total Operating Income As Reported |
|
-3.33
+41.33%
|
-5.68
+13.59%
|
-6.57
|
| EBITDA |
|
-3.50
+35.14%
|
-5.40
+12.80%
|
-6.20
|
| Normalized EBITDA |
|
-3.51
+34.80%
|
-5.39
+10.02%
|
-5.99
|
| Reconciled Depreciation |
|
0.08
-42.56%
|
0.14
-18.85%
|
0.17
|
| EBIT |
|
-3.58
+35.32%
|
-5.54
+12.95%
|
-6.36
|
| Total Unusual Items |
|
0.01
+147.30%
|
-0.02
+92.18%
|
-0.21
|
| Total Unusual Items Excluding Goodwill |
|
0.01
+147.30%
|
-0.02
+92.18%
|
-0.21
|
| Special Income Charges |
|
0.00
+100.00%
|
-0.02
+92.18%
|
-0.21
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
0.02
-92.18%
|
0.21
|
| Net Income |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Pretax Income |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Net Non Operating Interest Income Expense |
|
-0.13
-301.74%
|
0.07
-63.13%
|
0.18
|
| Interest Expense Non Operating |
|
0.16
+1135.23%
|
0.01
-54.70%
|
0.03
|
| Net Interest Income |
|
-0.13
-301.74%
|
0.07
-63.13%
|
0.18
|
| Interest Expense |
|
0.16
+1135.23%
|
0.01
-54.70%
|
0.03
|
| Interest Income Non Operating |
|
0.02
-73.07%
|
0.08
-62.00%
|
0.21
|
| Interest Income |
|
0.02
-73.07%
|
0.08
-62.00%
|
0.21
|
| Other Income Expense |
|
-0.27
-741.65%
|
0.04
+120.17%
|
-0.21
|
| Other Non Operating Income Expenses |
|
-0.28
-576.67%
|
0.06
+3033.05%
|
-0.00
|
| Gain On Sale Of Security |
|
0.01
|
—
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Net Income From Continuing And Discontinued Operation |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Net Income Continuous Operations |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Normalized Income |
|
-3.75
+32.32%
|
-5.54
+10.46%
|
-6.18
|
| Net Income Common Stockholders |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Diluted EPS |
|
—
|
-0.54
+13.14%
|
-0.62
|
| Basic EPS |
|
—
|
-0.54
+13.14%
|
-0.62
|
| Basic Average Shares |
|
—
|
10.35
+0.00%
|
10.35
|
| Diluted Average Shares |
|
—
|
10.35
+0.00%
|
10.35
|
| Diluted NI Availto Com Stockholders |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Assets |
|
4.14
+15.43%
|
3.58
-43.71%
|
6.37
|
| Current Assets |
|
1.47
-27.68%
|
2.03
-52.70%
|
4.30
|
| Cash Cash Equivalents And Short Term Investments |
|
1.03
-42.49%
|
1.78
-56.38%
|
4.09
|
| Cash And Cash Equivalents |
|
1.03
-42.49%
|
1.78
-56.38%
|
4.09
|
| Receivables |
|
0.20
+47.82%
|
0.14
+96.52%
|
0.07
|
| Accounts Receivable |
|
0.20
+47.82%
|
0.14
+96.52%
|
0.07
|
| Gross Accounts Receivable |
|
0.28
+70.70%
|
0.16
+67.67%
|
0.10
|
| Allowance For Doubtful Accounts Receivable |
|
-0.08
-176.16%
|
-0.03
+0.00%
|
-0.03
|
| Inventory |
|
0.12
+146.41%
|
0.05
-22.26%
|
0.06
|
| Prepaid Assets |
|
—
|
0.07
-16.80%
|
0.08
|
| Other Current Assets |
|
0.13
+90.28%
|
0.07
|
—
|
| Total Non Current Assets |
|
2.67
+71.99%
|
1.55
-25.02%
|
2.07
|
| Net PPE |
|
0.66
-25.54%
|
0.89
-24.50%
|
1.18
|
| Gross PPE |
|
1.82
+34.76%
|
1.35
-18.20%
|
1.65
|
| Accumulated Depreciation |
|
-1.16
-150.17%
|
-0.46
+2.65%
|
-0.48
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
|
| Other Properties |
|
1.57
+42.94%
|
1.10
-21.56%
|
1.40
|
| Leases |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
|
| Goodwill And Other Intangible Assets |
|
0.47
-5.16%
|
0.50
-5.20%
|
0.53
|
| Other Intangible Assets |
|
0.47
-5.16%
|
0.50
-5.20%
|
0.53
|
| Non Current Deferred Assets |
|
1.51
|
0.00
-100.00%
|
0.15
|
| Non Current Prepaid Assets |
|
—
|
0.11
-29.05%
|
0.15
|
| Other Non Current Assets |
|
0.02
-85.76%
|
0.16
+149.61%
|
0.06
|
| Total Liabilities Net Minority Interest |
|
4.16
+99.94%
|
2.08
-0.07%
|
2.08
|
| Current Liabilities |
|
2.46
+81.77%
|
1.36
+33.95%
|
1.01
|
| Payables And Accrued Expenses |
|
1.65
+130.11%
|
0.72
+21.24%
|
0.59
|
| Payables |
|
0.87
+133.29%
|
0.37
+3.34%
|
0.36
|
| Accounts Payable |
|
0.87
+133.29%
|
0.37
+3.34%
|
0.36
|
| Current Accrued Expenses |
|
0.79
+126.70%
|
0.35
+48.97%
|
0.23
|
| Current Debt And Capital Lease Obligation |
|
0.25
+51.21%
|
0.17
+1.17%
|
0.16
|
| Current Debt |
|
0.07
|
—
|
—
|
| Other Current Borrowings |
|
0.07
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.18
+6.18%
|
0.17
+1.17%
|
0.16
|
| Current Deferred Liabilities |
|
0.41
-11.81%
|
0.47
+84.58%
|
0.25
|
| Current Deferred Revenue |
|
0.41
-11.81%
|
0.47
+84.58%
|
0.25
|
| Other Current Liabilities |
|
0.14
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1.69
+133.95%
|
0.72
-32.27%
|
1.07
|
| Long Term Debt And Capital Lease Obligation |
|
1.11
+64.44%
|
0.67
-36.95%
|
1.07
|
| Long Term Debt |
|
0.62
|
—
|
0.23
|
| Long Term Capital Lease Obligation |
|
0.49
-27.47%
|
0.67
-19.74%
|
0.84
|
| Non Current Deferred Liabilities |
|
0.04
-16.37%
|
0.05
|
0.00
|
| Non Current Deferred Revenue |
|
0.04
-16.37%
|
0.05
|
0.00
|
| Stockholders Equity |
|
-0.02
-101.28%
|
1.51
-64.89%
|
4.29
|
| Common Stock Equity |
|
-0.07
-104.55%
|
1.46
-65.61%
|
4.24
|
| Capital Stock |
|
0.10
+6.93%
|
0.10
+1.20%
|
0.09
|
| Common Stock |
|
0.05
+12.84%
|
0.05
+1.05%
|
0.05
|
| Preferred Stock |
|
0.05
+0.84%
|
0.05
+1.35%
|
0.05
|
| Share Issued |
|
10.35
+0.00%
|
10.35
+0.00%
|
10.35
|
| Ordinary Shares Number |
|
10.35
+0.00%
|
10.35
+0.00%
|
10.35
|
| Additional Paid In Capital |
|
33.13
+7.04%
|
30.95
+9.94%
|
28.15
|
| Retained Earnings |
|
-33.25
-12.67%
|
-29.51
-23.17%
|
-23.96
|
| Total Equity Gross Minority Interest |
|
-0.02
-101.28%
|
1.51
-64.89%
|
4.29
|
| Total Capitalization |
|
0.60
-60.14%
|
1.51
-66.67%
|
4.52
|
| Working Capital |
|
-0.99
-246.07%
|
0.68
-79.35%
|
3.29
|
| Invested Capital |
|
0.63
-56.98%
|
1.46
-67.37%
|
4.47
|
| Total Debt |
|
1.36
+61.83%
|
0.84
-31.88%
|
1.23
|
| Capital Lease Obligations |
|
0.66
-20.83%
|
0.84
-16.32%
|
1.00
|
| Net Tangible Assets |
|
-0.49
-148.95%
|
1.01
-73.24%
|
3.76
|
| Tangible Book Value |
|
-0.54
-156.26%
|
0.96
-74.17%
|
3.71
|
| Derivative Product Liabilities |
|
0.54
|
0.00
|
—
|
| Other Equity Interest |
|
—
|
-0.03
|
—
|
| Preferred Stock Equity |
|
0.05
+0.84%
|
0.05
+1.35%
|
0.05
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
-1.92
+26.13%
|
-2.60
+41.99%
|
-4.48
|
| Cash Flow From Continuing Operating Activities |
|
-1.92
+26.13%
|
-2.60
+41.99%
|
-4.48
|
| Net Income From Continuing Operations |
|
-3.74
+32.65%
|
-5.55
+13.14%
|
-6.39
|
| Depreciation Amortization Depletion |
|
0.08
-42.56%
|
0.14
-18.85%
|
0.17
|
| Depreciation |
|
0.06
-51.02%
|
0.11
-20.53%
|
0.14
|
| Amortization Cash Flow |
|
0.02
+0.00%
|
0.02
-9.22%
|
0.02
|
| Depreciation And Amortization |
|
0.08
-42.56%
|
0.14
-18.85%
|
0.17
|
| Amortization Of Intangibles |
|
0.02
+0.00%
|
0.02
-9.22%
|
0.02
|
| Other Non Cash Items |
|
0.28
|
—
|
—
|
| Stock Based Compensation |
|
0.52
-76.28%
|
2.18
+66.88%
|
1.30
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.02
-92.18%
|
0.21
|
| Operating Gains Losses |
|
-0.01
|
—
|
—
|
| Gain Loss On Investment Securities |
|
-0.01
|
—
|
—
|
| Change In Working Capital |
|
0.84
+35.02%
|
0.62
+174.43%
|
0.23
|
| Change In Receivables |
|
-0.06
+2.64%
|
-0.07
-109.54%
|
0.70
|
| Changes In Account Receivables |
|
-0.06
+2.64%
|
-0.07
-109.54%
|
0.70
|
| Change In Inventory |
|
-0.07
-611.34%
|
0.01
-48.86%
|
0.03
|
| Change In Prepaid Assets |
|
0.08
-63.86%
|
0.22
+223.94%
|
0.07
|
| Change In Payables And Accrued Expense |
|
0.96
+398.08%
|
0.19
+138.28%
|
-0.50
|
| Change In Accrued Expense |
|
0.46
+155.69%
|
0.18
+144.96%
|
-0.40
|
| Change In Payable |
|
0.50
+4026.75%
|
0.01
+111.87%
|
-0.10
|
| Change In Account Payable |
|
0.50
+4026.75%
|
0.01
+111.56%
|
-0.10
|
| Change In Other Working Capital |
|
-0.06
-124.01%
|
0.27
+532.89%
|
-0.06
|
| Investing Cash Flow |
|
—
|
0.00
+100.00%
|
-0.04
|
| Cash Flow From Continuing Investing Activities |
|
—
|
0.00
+100.00%
|
-0.04
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.01
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.01
|
| Capital Expenditure |
|
—
|
—
|
-0.04
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.03
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-0.03
|
| Financing Cash Flow |
|
1.16
+296.03%
|
0.29
+250.91%
|
-0.19
|
| Cash Flow From Continuing Financing Activities |
|
1.16
+296.03%
|
0.29
+250.91%
|
-0.19
|
| Net Issuance Payments Of Debt |
|
0.99
|
0.00
+100.00%
|
-0.05
|
| Issuance Of Debt |
|
0.99
|
0.00
|
—
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-0.05
|
| Long Term Debt Issuance |
|
0.99
|
0.00
|
—
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-0.05
|
| Net Long Term Debt Issuance |
|
0.99
|
0.00
+100.00%
|
-0.05
|
| Net Common Stock Issuance |
|
0.00
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.00
|
| Net Other Financing Charges |
|
-0.02
|
—
|
-0.15
|
| Changes In Cash |
|
-0.76
+67.12%
|
-2.31
+51.14%
|
-4.72
|
| Beginning Cash Position |
|
1.78
-56.38%
|
4.09
-53.57%
|
8.81
|
| End Cash Position |
|
1.03
-42.49%
|
1.78
-56.38%
|
4.09
|
| Free Cash Flow |
|
-1.92
+26.13%
|
-2.60
+42.55%
|
-4.52
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
| Amortization Of Securities |
|
0.12
+2213.40%
|
0.00
-4.40%
|
0.01
|
| Change In Interest Payable |
|
0.04
+435.06%
|
0.01
-54.12%
|
0.02
|
| Common Stock Issuance |
|
0.00
|
0.00
|
—
|
| Issuance Of Capital Stock |
|
0.20
-32.81%
|
0.29
|
0.00
|
| Net Preferred Stock Issuance |
|
0.19
-34.43%
|
0.29
|
0.00
|
| Preferred Stock Issuance |
|
0.19
-34.43%
|
0.29
|
0.00
|
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|